|
 |
The Biogenerics Mark |
|
| Everyone is familiar with generic drugs that were once proprietary. As soon as the patent runs out, companies rush in with their version of a popular drug. |
|
|
 |
[RH] 二� 4�씪 洹쇰Т, �꽭怨� 理쒕�� |
|
| �꽭怨� 理쒕�� 洹쒕え�쓽 二� 4�씪 洹쇰Т �떎�뿕 寃곌낵媛� 怨듦컻�릺�뿀�떎. �븵�꽌 2022�뀈 6�썡遺��꽣 6媛쒖썡 �룞�븞 �쁺援��쓽 61媛� 湲곗뾽 諛� 湲곌���씠 �������엫 �깮�궛 紐⑺몴��� 湲됱뿬 �쟾�븸�쓣 �쑀吏��븯�릺 �쟾 吏곸썝�뱾�쓽 洹쇰Т �떆媛꾩쓣 20% �떒異뺥븯�뒗 �떎�뿕�뿉 李몄뿬�뻽�떎. |
|
|
 |
�쑖�빀�쓽 �떆���, 寃쎄퀎媛� �궗�씪吏��뒗 �쁺�떊�쓽 |
|
| �씤瑜섏쓽 吏꾨낫�뒗 �뒛 ��섎텇由р�숈뿉�꽌 �떆�옉�빐 ��섏쑖�빀��숈쑝濡� �셿�꽦�릺�뼱�솕�떎. 怨쇨굅�뿉�뒗 �솕�븰�옄�뒗 �솕�븰留�, �깮臾쇳븰�옄�뒗 �깮臾쇳븰留� �뿰援ы뻽�떎. 洹몃윭�굹 �삤�뒛�쓽 �쁺�떊��� �뜑 �씠�긽 �븰臾� �븞�뿉 媛뉙�� �엳吏� �븡�떎. 怨쇳븰�쓽 寃쎄퀎媛� �끃�븘�궡由ш퀬, �궛�뾽�쓽 遺꾪븷�꽑�씠 �궗�씪吏��뒗 吏�湲�, �꽭�긽��� �쑖�빀�삎 �쁺�떊�쓽 �떆���濡� 吏꾩엯�븯怨� �엳�떎. |
|
|
 |
Human + Machine |
|
| 저자 | Paul R. Daugherty �쇅 |
| 출판사 | Harvard Business Review Press |
|
 |
|
|
| 저자 | |
| 출판사 | |
|
[77]권 
